Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Misonix Inc (MSON)

Misonix Inc (MSON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Misonix Inc 1938 NEW HIGHWAY FARMINGDALE NY 11735 USA

www.misonix.com P: 631-694-9555 F: 631-694-9412

Description:

Misonix, Inc. designs, develops, manufactures, and markets medical, scientific, and industrial ultrasonic equipment, laboratory safety equipment, and air pollution control products. Misonix's ultrasonic platform is the basis for several innovative medical technologies. Misonix has a minority equity position in Focus Surgery, Inc. which uses high intensity focused ultrasound technology to destroy deep-seated cancerous tissues without affecting surrounding healthy tissue. Misonix acquired worldwide rights to use the Focus technology in kidney, liver and breast treatment. Addressing a combined market estimated to be in excess of $four billion annually, Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications.

Key Statistics

Overview:

Market Capitalization, $K 462,061
Shares Outstanding, K 17,410
Annual Sales, $ 74,020 K
Annual Net Income, $ -14,470 K
Last Quarter Sales, $ 19,690 K
Last Quarter Net Income, $ -4,470 K
60-Month Beta 1.36
% of Insider Shareholders 31.69%
% of Institutional Shareholders 40.52%
Float, K 11,893
% Float 68.31%

Growth:

1-Year Return 133.01%
3-Year Return 61.44%
5-Year Return 227.65%
5-Year Revenue Growth 220.29%
5-Year Earnings Growth -394.12%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 11/04/21
Earnings Per Share ttm -0.84
EPS Growth vs. Prev Qtr -18.18%
EPS Growth vs. Prev Year 48.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 3-2 on 10/21/97

MSON Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -10.36%
Return-on-Assets % -7.29%
Profit Margin % -19.55%
Debt/Equity 0.29
Price/Sales 5.96
Price/Cash Flow N/A
Price/Book 3.42
Book Value/Share 7.77
Interest Coverage -2.96
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar